Panel: AI Enabled QM&QI: Opportunities and Obstacles
Mortazavi, Bobak
(
Texas AM University
, College Station , Texas , United States )
Golbus, Jessica
(
UNIVERSITY OF MICHIGAN
, Ann Arbor , Michigan , United States )
Peterson, Eric
(
UT Southwestern Medical Center
, Dallas , Texas , United States )
Ahmad, Faraz
(
NORTHWESTERN UNIV SCHOOL MEDICINE
, Chicago , Illinois , United States )
Author Disclosures:
Bobak Mortazavi:DO have relevant financial relationships
;
Other (please indicate in the box next to the company name):Kirkland & Ellis, Expert Witness:Active (exists now)
; Research Funding (PI or named investigator):NSF:Active (exists now)
; Research Funding (PI or named investigator):NIDDK:Active (exists now)
; Research Funding (PI or named investigator):NHLBI:Active (exists now)
; Individual Stocks/Stock Options:Google:Active (exists now)
; Individual Stocks/Stock Options:Nvidia:Active (exists now)
; Individual Stocks/Stock Options:Microsoft:Active (exists now)
; Individual Stocks/Stock Options:Apple:Active (exists now)
| Jessica Golbus:DO NOT have relevant financial relationships
| Eric Peterson:DO have relevant financial relationships
;
Research Funding (PI or named investigator):Amgen:Active (exists now)
; Consultant:Janssen:Active (exists now)
; Consultant:Novo NorDisk:Active (exists now)
| Faraz Ahmad:DO have relevant financial relationships
;
Research Funding (PI or named investigator):Pfizer:Past (completed)
; Consultant:AstraZeneca:Past (completed)
; Speaker:AstraZeneca:Past (completed)
; Speaker:Alnylam:Past (completed)
; Consultant:Alnylam Pharmceuticals:Active (exists now)
; Research Funding (PI or named investigator):Abiomed/Johnson and Johnson:Active (exists now)
; Research Funding (PI or named investigator):AstraZeneca:Active (exists now)
; Research Funding (PI or named investigator):Atman Health:Past (completed)
; Research Funding (PI or named investigator):Tempus:Active (exists now)
; Research Funding (PI or named investigator):Atman Health :Past (completed)